Accelerate Diagnostics Inc. - notizie pubblicate 238 - letture 6.050


Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Initial Registration Statement for Employee Benefit Plan - Form S-8

As filed with the securities and exchange commission on may 14, 2024 registration no. 333-               united states securities and exchange commissio ...

15.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.02. departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. as discussed in item 5 ...

13.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)

Axdx-20240331 united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☑ quarterly report pursuant to section 13 or 15(d) of the securities ex ...

13.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Amendment to Current Report - Form 8-K/A

Accelerate diagnostics, inc. condensed consolidated balance sheets unaudited (in thousands, except share data) march 31, december 31, 2024 2023 assets current assets: cash and cash ...

10.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results - Form 8-K

Accelerate diagnostics reports preliminary first quarter 2024 financial results tucson, ariz., may 8, 2024 -- accelerate diagnostics, inc. (nasdaq: axdx) today announced financial ...

08.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

Tucson, ariz., may 8, 2024/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced financial preliminary results for the first quarter ended march 31, 2024. &quo ...

08.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

Tucson, ariz., may 2, 2024/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) announced today that management will host a conference call on wednesday, may 8, 2024, at 4:30 ...

02.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

Tucson, ariz., may 2, 2024/prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) announced today that management will host a conference call on wednesday, may 8, 2024, at 4:30 ...

02.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Failure to Satisfy Listing Rule - Form 8-K

Item 3.01. notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. on april 26, 2024, accelerate diagnostics, inc. (the "company&q ...

02.05.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

18.04.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

16.04.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Proxy Statement - Form DEF 14A

United states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 filed by the r ...

11.04.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

10.04.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics Announces 510(k) Submission of the Accelerate Arc™ System to the FDA

Accelerate diagnostics announces 510(k) submission of the accelerate arc™ system to the fda apr 09, 2024 enabling rapid, automated microbial identification directly from positive ...

09.04.2024
Accelerate Diagnostics Inc.

ACCELERATE DIAGNOSTICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

05.04.2024
Condividi